Cardiovascular Calcification Market is segmented By Therapy Type (Marketed Drugs, Emerging Drugs), By Geography (North America, Latin America, Asia Pacific, Europe, Middl ....
Market Size in USD
CAGR4.9%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 4.9% |
Market Concentration | High |
Major Players | Sanifit, Inositec, Sanofi, Dong-A ST |
The cardiovascular calcification market is estimated to be valued at USD 125.2 billion in 2024 and is expected to reach USD 174.6 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
Cardiovascular calcification has been growing in prevalence over the past decade globally. Additionally, the growing adoption of technologically advanced imaging modalities for the diagnosis of cardiovascular calcification is driving the market.